Tvardi Therapeutics, Inc. TVRD
1.41 USD +0.46 (+48.11%)
At closeNov 9, 2026, 7:59 PM EST
1.55 +0.14 +9.93%
After hours · Nov 9, 7:59 PM ET
0.9577 Day range 1.61
0.773 52-week range 5.69
- YTD
- -67.21%
- 1 year
- -64.93%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -26.75M | -28.11M | -121.50M | -87.53M | -89.08M | |
| -18.21M | -29.40M | -118.51M | -85.47M | -88.44M | |
| -3.26 | -11.42 | -79.00 | -57.00 | -63.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 20.73M | 31.61M | 52.18M | 64.15M | 13.45M | |
| 32.07M | 35.20M | 125.84M | 182.24M | 247.06M | |
| 11.13M | 40.83M | 68.76M | 23.46M | 19.53M | |
| 201.00K | 30.56M | 43.17M | 1.92M | 3.67M | |
| 20.95M | -91.13M | 57.09M | 158.78M | 227.52M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -23.50M | -18.30M | -92.08M | -78.73M | -60.09M | |
| -10.08M | 0 | 43.46M | 128.71M | -4.75M | |
| 22.70M | 27.00M | 38.15M | 311.00K | 46.61M | |
| -10.88M | 8.70M | -10.47M | 50.29M | -18.23M |